BCH’s Earnings Can’t Escape the Downward Slide

Bangkok Chain Hospital PCL (BCH) is scheduled to release its earnings for the 2026 quarter on May 15, 2026. Historical earnings data, however, reveals a mixed performance across the past few quarters. For the December 2025 quarter, the company reported an EPS of 0.1, falling short of the 0.14 forecast, while revenue came in at 2.97 billion THB versus the projected 3.05 billion THB. The EPS and revenue surprises were -28.57% and -2.62% respectively, and the stock price dropped by 9.65% following the report. In the preceding September 2025 quarter, BCH also underperformed expectations, posting an EPS of 0.14 against the 0.17 forecast and revenue of 3.03 billion THB versus 3.24 billion THB, with the stock down 3.60% in that period.

The March 2025 quarter marked one of the few positive surprises, as EPS came in at 0.16 versus the 0.14 forecast, with revenue matching the 3.02 billion THB forecast exactly. Despite the positive EPS surprise of 14.29%, the stock still declined by 6.38%. The pattern of earnings results shows that while BCH has occasionally exceeded forecasts, the stock has generally declined in the aftermath of these reports, indicating that market expectations may be difficult to exceed consistently.

In the broader market context, BCH has experienced a steady decline over the past year, dropping by 22.85% as of April 1, 2026. Over the 24-hour period, the stock fell by 0.84%, and it has lost 2.2% in the past seven days and 0.86% over the last month. These declines suggest that investor sentiment has been bearish, and the recent earnings history may have contributed to the downward pressure on the stock.

Analysts have not provided a clear path forward for BCH stock. With mixed earnings results and a history of underperformance, the market appears cautious. While the upcoming earnings report may provide new insights, the current trajectory indicates that the stock is trading lower on a year-over-year basis, and continued volatility is possible as investors assess the company’s performance against expectations.

The May 2026 earnings date offers a key opportunity for investors to gauge whether BCH can reverse its recent performance trend. Until then, the bearish sentiment reflected in the price movements over the past year will likely remain a focal point for market participants.